NextPlat (NXPL) Gross Profit (2015 - 2026)
NextPlat's (NXPL) quarterly Gross Profit came in at $4.7 million in Q2 2026, up 62.82% year-over-year from $2.9 million in Q2 2025, and up 37.57% quarter-over-quarter from $3.4 million in Q1 2026.
Analysis
NextPlat (NXPL) Gross Profit (2015 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Gross Profit for 12 consecutive years, with $4.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Gross Profit rose 62.82% year-over-year to $4.7 million in Q2 2026; TTM through Jun 2026 was $12.7 million, a 5.25% increase from a year earlier, with the FY2025 full-year figure at $10.9 million, down 35.88% from the prior year.
- Gross Profit was $4.7 million for Q2 2026 at NextPlat, up from $3.4 million in the prior quarter.
- Over five years, Gross Profit peaked at $5.9 million in Q2 2024 and troughed at $441764.0 in Q4 2022.
- A 5-year average of $2.7 million and a median of $2.8 million in 2025 frame the typical range for Gross Profit.
- Across the five-year window, Gross Profit soared 1091.13% in 2023 and slumped 50.79% in 2025, its largest moves.
- Over 5 years, Gross Profit stood at $441764.0 in 2022, then soared by 1091.13% to $5.3 million in 2023, then sank by 48.14% to $2.7 million in 2024, then tumbled by 32.94% to $1.8 million in 2025, then jumped by 156.5% to $4.7 million in 2026.
- The last three Gross Profit figures came in at $4.7 million (Q2 2026), $3.4 million (Q1 2026), and $1.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.69 Mn |
| Mar 31, 2026 | 3.41 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | 2.73 Mn |
| Jun 30, 2025 | 2.88 Mn |
| Mar 31, 2025 | 2.86 Mn |
| Dec 31, 2024 | 2.73 Mn |
| Sep 30, 2024 | 3.56 Mn |
| Jun 30, 2024 | 5.86 Mn |
| Mar 31, 2024 | 4.86 Mn |
| Dec 31, 2023 | 5.26 Mn |
| Sep 30, 2023 | 4.59 Mn |
| Jun 30, 2023 | 844,000.00 |
| Mar 31, 2023 | 621,000.00 |
| Dec 31, 2022 | 441,764.00 |
| Sep 30, 2022 | 678,754.00 |
| Jun 30, 2022 | 567,389.00 |
| Mar 31, 2022 | 801,093.00 |
| Dec 31, 2021 | 387,580.00 |
| Sep 30, 2021 | 493,136.00 |